Kura Oncology, Inc.KURANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank86
3Y CAGR+42.2%
5Y CAGR-14.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+42.2%/yr
vs +33.9%/yr prior
5Y CAGR
-14.5%/yr
Recent acceleration
Acceleration
+8.4pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $149.10M | -33.6% |
| 2024 | $224.46M | +501.5% |
| 2023 | $37.32M | -28.0% |
| 2022 | $51.80M | -42.9% |
| 2021 | $90.67M | -72.1% |
| 2020 | $325.49M | +1145.4% |
| 2019 | $26.14M | +62.1% |
| 2018 | $16.12M | +41.0% |
| 2017 | $11.43M | +17.6% |
| 2016 | $9.72M | - |